Clinical Trials in New York State

Showing 2061-2080 of 8,190 trials

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

NCT05580588

Study SPH4336-US-01 is an open-label (no placebo), multicenter clinical trial to evaluate the safety, blood levels (pharmacokinetics) and preliminary anti-tumor effects of SPH4336, a selective enzyme blocker, in patients with specific types of liposarcomas (tumors expressing the target of the study drug).

Liposarcoma, Dedifferentiated

Shanghai Pharma Biotherapeutics USA Inc.14 participantsStarted Aug 2023

Phoenix, Arizona, United States • Duarte, California, United States • Jacksonville, Florida, United States +6 more locations

COMPLETEDPhase 3107 miles

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

NCT04462536

The primary purpose of this study is to determine if a single dose of nerinetide can reduce global disability in people who have had a stroke and are selected for endovascular therapy without the use of a tissue plasminogen activator (alteplase, tenecteplase, or equivalent).

Stroke, Acute

NoNO Inc.850 participantsStarted Dec 2020

Phoenix, Arizona, United States • Torrance, California, United States • Englewood, Colorado, United States +78 more locations

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Find Trials by Condition in New York State

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

RemI for Post-Bariatric Surgery Weight Regain

EluPro Antibiotic-Eluting BioEnvelope Registry

Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies